Aframomum Melegueta Extract Targets Endocannabinoid System to Provide Clinically Demonstrated Benefits in as Little as 3 Days

Cognitive Health Ingredient Offers Reduced Stress, Enhanced Mood and Improved Sleep

The clinical study  on Vanizem is currently not published, but we’d like to provide you with more information on the trial. Please fill out the form on this page and we will contact you.

Clinical Support for Enhanced Mood and  Improved Sleep

 Thirty participants, aged between 40 and 50 years (44% women) were randomized into a placebo-controlled cross-over study to assess the effect of Vanizem at different doses. All participants

were healthy adults experiencing day-to-day stress. At the start of the trial each participant scored greater than 18 points on a modified-Hamilton Anxiety Rating Scale (mHAM-A), which indicated their tendency toward anxious feelings.